Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …

Conclusion The next several years will bring about dynamic shifts in the etiology of chronic
liver disease and demographic composition of those with cirrhosis. These changes will have …

The prevalence and cumulative incidence of hepatic encephalopathy (HE) are difficult to
state precisely. Thirty percent to 45% of cirrhotic patients could be affected by overt hepatic …

Hepatic encephalopathy (HE) is one of the most disabling metabolic diseases. It consists of
a complication of liver disease through the action of neurotoxins, such as excessive …

Methods: Adult patients with cirrhosis and HE were identified from the IBM MarketScan
claims database. Those who began rifaximin treatment between January 1, 2011, and …

Background and aims Patients with cirrhosis commonly experience minimal hepatic
encephalopathy (MHE), and alterations in neurotransmitters have been thought to be related …

Hepatic encephalopathy (HE) is an important complication of decompensated liver disease.
Hospital admission for episodes of HE are very common, with these patients being managed …

Hepatic encephalopathy (HE) is a common complication of advanced liver disease and
acute liver failure. It is a condition that features several neuropsychiatric symptoms that affect …

Background and aims Minimal hepatic encephalopathy (MHE) is a common
neuropsychiatric complication in patients with cirrhosis. Alterations in monoamine …

Due to its complex pathogenesis, treatment of hepatic encephalopathy (HE) continues to be
a therapeutic challenge. Of late, gut microbiome has garnered much attention for its role in …